Showing results for
Vaccine Development

£200,000 funding boost for Oxford’s Clinical BioManufacturing Facility

£200,000 funding boost for Oxford’s Clinical BioManufacturing Facility

Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds

Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds

Study reveals COVID-19 vaccine response in patients with impaired immune systems

Study reveals COVID-19 vaccine response in patients with impaired immune systems

Making a billion doses of vaccine in 18 months: starting with two tablespoons

Making a billion doses of vaccine in 18 months: starting with two tablespoons

African trial of novel HIV vaccine candidate starts

African trial of novel HIV vaccine candidate starts

One billion doses: A moment to celebrate but not a time to be complacent

One billion doses: A moment to celebrate but not a time to be complacent

Oxford vaccine reaches one billion doses released

Oxford vaccine reaches one billion doses released

First trial participants vaccinated with Oxford COVID-19 variant vaccine

First trial participants vaccinated with Oxford COVID-19 variant vaccine

Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study

Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study

Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response

Delayed second dose and third doses of the Oxford-AstraZeneca vaccine lead to heightened immune response